Best in Biotech 21 May 2024 Eight companies spearheading Philadelphia’s biotech industry …therapies for patients suffering from central nervous system (CNS) disorders. The company’s primary focus is on creating one-time gene therapies designed to address the underlying pathology of neurodegenerative diseases. Passage… May 21, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Interview 9 Nov 2017 Meet the Spin-Out Queen Taking on Neurological Diseases …continue focusing on neurokinins, neuropeptides found in the CNS that stimulate nerve receptors. KanDy spun out from NeRRe to concentrate on a new, dual neurokinin antagonist. NeRRe focuses exclusively on… November 9, 2017 - 4 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
In Depth 29 Apr 2024 Can Brazil make cell and gene therapy costs affordable for all? …chief executive officer (CEO) of Vyro Bio, a Brazilian company developing next-generation viral immunotherapies to treat aggressive, fast-growing forms of central nervous system (CNS) tumors. “Nowadays, with the development of… April 29, 2024 - 6 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 10 Jan 2024 The biggest private biotech investments in December 2023 The companies Tome Biosciences, Bicara Therapeutics, and Seismic Therapeutic bagged the biggest biotech investments in December 2023. Around the world, food, immunology, oncology, central nervous system (CNS), and biofermentation players… January 10, 2024 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
In Depth 5 May 2023 The biggest private biotech investments in April 2023 …B financing to support phase 1 and 2 trials of its human pluripotent stem cell candidates for lung diseases, degenerative joint diseases, central nervous system (CNS) diseases, and more. Other… May 5, 2023 - 3 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 28 Nov 2017 New Gene Therapy for Parkinson’s will be Developed in the UK …a therapeutic gene in specific neuron subpopulations within the central nervous system (CNS). This approach of addressing only specific targets has the potential to cut down on side effects and… November 28, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 2 Oct 2023 PIPEs in biotech fundraising: is this growing trend fueled by economic uncertainty here to stay? …the plug on its lead gene therapy candidate for the treatment of a rare central nervous system (CNS) disorder, following a U.S. Food and Drug Administration (FDA) meeting, it now… October 2, 2023 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 26 Mar 2025 A guide to kinase inhibitors in biotech: From cancer breakthroughs to autoimmune innovations …for TKIs, and resistance is a key challenge. NVL-655 is a selective ALK inhibitor designed to address resistance mutations and improve central nervous system (CNS) penetration. Early trial results have… March 26, 2025 - 9 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
News and Trends 21 Mar 2017 A Potential First Treatment for a Rare Genetic Disease clears Phase I …tolerability of the drug. X-ALD affects around 1 in 17,000 live births and is a congenital disease which results in severe damage to the central nervous system (CNS). Mutations in… March 21, 2017 - 2 minutesmins - By Melanie De Almeida Share WhatsApp Twitter Linkedin Email
Startup Scout 16 Mar 2018 This Belgian Biotech Could Speed Up Diagnoses for Neurodegenerative Diseases …consider whether targeting the disease early is the key to getting treatments to work. Biomarkers do have limitations, such as the high cost of CNS biomarkers or invasive procedures associated… March 16, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 14 Nov 2016 Meet one of the Most Impressive French Biotech Entrepreneurs …brain and the CNS field. I was particularly interested in this area as a cemetery of failed biotech companies and products at that time, which remains true even now despite… November 14, 2016 - 6 minutesmins - By Philip Hemme Share WhatsApp Twitter Linkedin Email
Best in Biotech 28 May 2024 8 Swedish companies spearheading the country’s biotech scene …Hamlet BioPharma is also investigating the candidate for central nervous system (CNS)-related tumors. Animal studies have shown that it markedly delayed the development of glioblastoma. Additionally, the company has BAMLET… May 28, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email